Sara Weymer active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BOUNDLESS BIO, INC. | Chief Tech/Sci/R&D Officer | 04/06/2022 | - |
ZZ Biotech LLC
 ZZ Biotech LLC BiotechnologyHealth Technology ZZ Biotech LLC operates as a clinical stage company. It develops biologic treatments for ischemic stroke and other neurological diseases and wound healing applications including the treatment of diabetic foot ulcers. The firm mainly focuses on developing 3K3A-APC, a novel second-generation variant of a naturally occurring human protein licensed from The Scripps Research Institute. The company was founded by Selim Zilkha and Berislav V. Zlokovic in 2006 and is headquartered in Houston, TX. | Corporate Officer/Principal | - | - |
Career history of Sara Weymer
Former positions of Sara Weymer
| Companies | Position | Start | End |
|---|---|---|---|
| FATE THERAPEUTICS, INC. | Director/Board Member | - | - |
| Corporate Officer/Principal | - | - |
Statistics
International
| United States | 4 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| BOUNDLESS BIO, INC. | Health Technology |
| FATE THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
ZZ Biotech LLC
ZZ Biotech LLC BiotechnologyHealth Technology ZZ Biotech LLC operates as a clinical stage company. It develops biologic treatments for ischemic stroke and other neurological diseases and wound healing applications including the treatment of diabetic foot ulcers. The firm mainly focuses on developing 3K3A-APC, a novel second-generation variant of a naturally occurring human protein licensed from The Scripps Research Institute. The company was founded by Selim Zilkha and Berislav V. Zlokovic in 2006 and is headquartered in Houston, TX. | Health Technology |
- Stock Market
- Insiders
- Sara Weymer
- Experience
